Market Overview:
The global cough and cold remedies market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to factors such as the increasing prevalence of respiratory diseases, rising consumer awareness about over-the-counter (OTC) cough and cold remedies, and the growing demand for prescription-based cough and cold remedies. The global cough and cold remedies market is segmented on the basis of type into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. The antihistamines segment is expected to account for the largest share of the global market in 2018 owing to its high usage in both OTC as well as prescription-based formulations. The antibiotics segment is projected to grow at a highest CAGR during the forecast period due to an increase in antibiotic resistance across various regions worldwide.
Product Definition:
A cough and cold remedy is a medication that is used to treat symptoms of a cold or the flu. Cough and cold remedies are available over the counter or by prescription. They are typically taken orally in the form of tablets, capsules, liquids, or syrups.
Antihistamines:
Antihistamines are drugs that reduce the histamine response. The body normally produces histamine in response to food allergies or other irritants. Some people have a genetic tendency to produce morehistamine than others and these people may experience symptoms of an allergic reaction even after taking small doses of an antihistaminic drug. Antihistamines can be used for the treatment of itching, sneezing, watery eyes, runny nose and congestion due to colds or allergies.
Expectorants:
Expectorants are drugs that stimulate the cough mechanism to produce expectoration. It works by increasing the flow of mucous from the lungs and upper airways, which helps in getting rid of phlegm. These products act as a substitute or alternative to oral cough medicines without any proven effect on cold symptoms.
These products have been found useful in treating acute bronchitis, chronic bronchitis, asthma, and other lung diseases where there is excessive mucus production.
Application Insights:
OTC medicines accounted for the largest share of more than 70.0% in 2017 owing to the availability of a large number of generic and brand-name products available in the market. The segment is expected to witness significant growth during forecast years due to growing awareness about cold and cough remedies among consumers, coupled with rising incidences of these diseases across the globe.
The prescription segment is also anticipated to witness considerable growth over the forecast period owing to an increase in healthcare spending by governments as well as individuals, which has resulted in increased adoption of OTC medicines for cough and cold treatment. Prescription drugs have more active ingredients than OTC medicines, which makes them effective against coughs and colds caused by infection or allergies respectively.
Global curently there are few prescription only drugs that treat Cough & Cold (Tussionex), but expect this situation will change soon due largely on increasing use offor treating Cough & Cold (Tussionex).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high consumer awareness and availability of a wide range of products. Asia Pacific is projected to be the fastest-growing regional market from 2018 to 2030 owing to increasing disposable income, rising health consciousness, and growing demand for OTC drugs in this region. Moreover, an increase in cold chain distribution network will boost product sales over the forecast period. Bronchodilators are among most popular medicines prescribed by physicians for cough and cold remedy treatment; however, expectorants are more effective than bronchodilators for these purposes (Unger et al., 2016). Antihistamines have been found most effective against runny nose due both their ability as antihistamine or anti-inflammatory agent as well as expectorant property (Kumar & Gupta 2012).
The key players operating in North America include Actavis plc.; Cipla Inc.
Growth Factors:
- Increasing awareness about the benefits of using cough and cold remedies.
- Growing demand for natural and herbal cough and cold remedies.
- Rising incidence of respiratory infections worldwide.
- increasing adoption of over-the-counter (OTC) cough and cold remedies by consumers globally
Scope Of The Report
Report Attributes
Report Details
Report Title
Cough and Cold Remedie Market Research Report
By Type
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others, Cough and Cold Remedi
By Application
OTC, Rx
By Companies
Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble, Cough and Cold Remedi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Cough and Cold Remedie Market Report Segments:
The global Cough and Cold Remedie market is segmented on the basis of:
Types
Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others, Cough and Cold Remedi
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
OTC, Rx
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Reckitt Benckiser Group
- Johnson & Johnson
- GlaxoSmithKline
- Novartis
- Bayer
- AstraZeneca
- Sun Pharmaceutical Industries
- Pfizer
- Prestige Brands Holdings
- Procter & Gamble
- Cough and Cold Remedi
Highlights of The Cough and Cold Remedie Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
- Cough and Cold Remedi
- By Application:
- OTC
- Rx
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cough and Cold Remedie Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cough and cold remedy is a medication that is used to treat coughs and colds. It can be taken by mouth or as a nasal spray. Cough and cold remedy may also be used to prevent the development of coughs and colds.
Some of the major companies in the cough and cold remedie market are Reckitt Benckiser Group, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, AstraZeneca, Sun Pharmaceutical Industries, Pfizer, Prestige Brands Holdings, Procter & Gamble, Cough and Cold Remedi.
The cough and cold remedie market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cough and Cold Remedie Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Cough and Cold Remedie Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Cough and Cold Remedie Market - Supply Chain
4.5. Global Cough and Cold Remedie Market Forecast
4.5.1. Cough and Cold Remedie Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Cough and Cold Remedie Market Size (000 Units) and Y-o-Y Growth
4.5.3. Cough and Cold Remedie Market Absolute $ Opportunity
5. Global Cough and Cold Remedie Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Cough and Cold Remedie Market Size and Volume Forecast by Type
5.3.1. Antihistamines
5.3.2. Expectorants
5.3.3. Bronchodilators
5.3.4. Decongestants
5.3.5. Antibiotics
5.3.6. Others
5.3.7. Cough and Cold Remedi
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Cough and Cold Remedie Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Cough and Cold Remedie Market Size and Volume Forecast by Application
6.3.1. OTC
6.3.2. Rx
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Cough and Cold Remedie Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Cough and Cold Remedie Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Cough and Cold Remedie Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Cough and Cold Remedie Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Cough and Cold Remedie Demand Share Forecast, 2019-2026
9. North America Cough and Cold Remedie Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Cough and Cold Remedie Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Cough and Cold Remedie Market Size and Volume Forecast by Application
9.4.1. OTC
9.4.2. Rx
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Cough and Cold Remedie Market Size and Volume Forecast by Type
9.7.1. Antihistamines
9.7.2. Expectorants
9.7.3. Bronchodilators
9.7.4. Decongestants
9.7.5. Antibiotics
9.7.6. Others
9.7.7. Cough and Cold Remedi
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Cough and Cold Remedie Demand Share Forecast, 2019-2026
10. Latin America Cough and Cold Remedie Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Cough and Cold Remedie Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Cough and Cold Remedie Market Size and Volume Forecast by Application
10.4.1. OTC
10.4.2. Rx
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Cough and Cold Remedie Market Size and Volume Forecast by Type
10.7.1. Antihistamines
10.7.2. Expectorants
10.7.3. Bronchodilators
10.7.4. Decongestants
10.7.5. Antibiotics
10.7.6. Others
10.7.7. Cough and Cold Remedi
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Cough and Cold Remedie Demand Share Forecast, 2019-2026
11. Europe Cough and Cold Remedie Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Cough and Cold Remedie Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Cough and Cold Remedie Market Size and Volume Forecast by Application
11.4.1. OTC
11.4.2. Rx
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Cough and Cold Remedie Market Size and Volume Forecast by Type
11.7.1. Antihistamines
11.7.2. Expectorants
11.7.3. Bronchodilators
11.7.4. Decongestants
11.7.5. Antibiotics
11.7.6. Others
11.7.7. Cough and Cold Remedi
11.8. Basis Poin Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Cough and Cold Remedie Demand Share, 2019-2026
12. Asia Pacific Cough and Cold Remedie Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Cough and Cold Remedie Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Cough and Cold Remedie Market Size and Volume Forecast by Application
12.4.1. OTC
12.4.2. Rx
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Cough and Cold Remedie Market Size and Volume Forecast by Type
12.7.1. Antihistamines
12.7.2. Expectorants
12.7.3. Bronchodilators
12.7.4. Decongestants
12.7.5. Antibiotics
12.7.6. Others
12.7.7. Cough and Cold Remedi
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Cough and Cold Remedie Demand Share, 2019-2026
13. Middle East & Africa Cough and Cold Remedie Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Cough and Cold Remedie Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Cough and Cold Remedie Market Size and Volume Forecast by Application
13.4.1. OTC
13.4.2. Rx
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Cough and Cold Remedie Market Size and Volume Forecast by Type
13.7.1. Antihistamines
13.7.2. Expectorants
13.7.3. Bronchodilators
13.7.4. Decongestants
13.7.5. Antibiotics
13.7.6. Others
13.7.7. Cough and Cold Remedi
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Cough and Cold Remedie Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Cough and Cold Remedie Market: Market Share Analysis
14.2. Cough and Cold Remedie Distributors and Customers
14.3. Cough and Cold Remedie Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Reckitt Benckiser Group
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bayer
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AstraZeneca
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceutical Industries
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Prestige Brands Holdings
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Procter & Gamble
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cough and Cold Remedi
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
